Rallybio Corporation (RLYB)

Rallybio Statistics

Total Valuation

Rallybio has a market cap or net worth of $48.40 million. The enterprise value is -$7.59 million.

Market Cap	48.40M
Enterprise Value	-7.59M

Important Dates

The next estimated earnings date is Monday, May 11, 2026, before market open.

Earnings Date	May 11, 2026
Ex-Dividend Date	n/a

Share Statistics

Rallybio has 5.29 million shares outstanding. The number of shares has increased by 3.42% in one year.

Current Share Class	5.29M
Shares Outstanding	5.29M
Shares Change (YoY)	+3.42%
Shares Change (QoQ)	+0.90%
Owned by Insiders (%)	4.16%
Owned by Institutions (%)	28.24%
Float	3.16M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	54.75
Forward PS	n/a
PB Ratio	0.81
P/TBV Ratio	0.81
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 14.50, with a Debt / Equity ratio of 0.00.

Current Ratio	14.50
Quick Ratio	12.96
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -15.01% and return on invested capital (ROIC) is -32.69%.

Return on Equity (ROE)	-15.01%
Return on Assets (ROA)	-30.07%
Return on Invested Capital (ROIC)	-32.69%
Return on Capital Employed (ROCE)	-54.04%
Weighted Average Cost of Capital (WACC)	-2.33%
Revenue Per Employee	$61,286
Profits Per Employee	-$641,286
Employee Count	14
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +269.91% in the last 52 weeks. The beta is -1.13, so Rallybio's price volatility has been lower than the market average.

Beta (5Y)	-1.13
52-Week Price Change	+269.91%
50-Day Moving Average	8.57
200-Day Moving Average	5.81
Relative Strength Index (RSI)	62.07
Average Volume (20 Days)	59,773

Short Selling Information

The latest short interest is 1.41 million, so 26.58% of the outstanding shares have been sold short.

Short Interest	1.41M
Short Previous Month	1.11M
Short % of Shares Out	26.58%
Short % of Float	44.46%
Short Ratio (days to cover)	15.30

Income Statement

In the last 12 months, Rallybio had revenue of $858,000 and -$8.98 million in losses. Loss per share was -$1.59.

Revenue	858,000
Gross Profit	-17.54M
Operating Income	-31.36M
Pretax Income	-8.98M
Net Income	-8.98M
EBITDA	-31.27M
EBIT	-31.36M
Loss Per Share	-$1.59

Balance Sheet

The company has $54.74 million in cash and $176,000 in debt, with a net cash position of $54.56 million or $10.31 per share.

Cash & Cash Equivalents	54.74M
Total Debt	176,000
Net Cash	54.56M
Net Cash Per Share	$10.31
Equity (Book Value)	57.96M
Book Value Per Share	10.97
Working Capital	57.03M

Cash Flow

Operating Cash Flow	-29.81M
Capital Expenditures	n/a
Depreciation & Amortization	92,000
Net Borrowing	n/a
Free Cash Flow	-29.81M
FCF Per Share	-$5.64

Margins

Gross Margin	n/a
Operating Margin	-3,655.48%
Pretax Margin	-1,046.39%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Rallybio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.42%
Shareholder Yield	-3.42%
Earnings Yield	-19.11%
FCF Yield	-63.47%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	220.74%
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on February 6, 2026. It was a reverse split with a ratio of 1:8.

Last Split Date	Feb 6, 2026
Split Type	Reverse
Split Ratio	1:8

Scores

Rallybio has an Altman Z-Score of -4.02 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-4.02
Piotroski F-Score	3